BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2686537)

  • 1. ras proteins: biological effects and biochemical targets (review).
    Bar-Sagi D
    Anticancer Res; 1989; 9(5):1427-37. PubMed ID: 2686537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of p21 ras proteins.
    Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
    Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function.
    Katzav S; Packham G; Sutherland M; Aroca P; Santos E; Cleveland JL
    Oncogene; 1995 Sep; 11(6):1079-88. PubMed ID: 7566967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin signaling to NF-kappa B in monocytic leukemia cells is blocked by activated oncogenes.
    Rosales C; Juliano R
    Cancer Res; 1996 May; 56(10):2302-5. PubMed ID: 8625304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells.
    Cox AD; Brtva TR; Lowe DG; Der CJ
    Oncogene; 1994 Nov; 9(11):3281-8. PubMed ID: 7936652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
    Zohn IM; Campbell SL; Khosravi-Far R; Rossman KL; Der CJ
    Oncogene; 1998 Sep; 17(11 Reviews):1415-38. PubMed ID: 9779988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras regulatory interactions: novel targets for anti-cancer intervention?
    Prendergast GC; Gibbs JB
    Bioessays; 1994 Mar; 16(3):187-91. PubMed ID: 8166672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
    Koskinen PJ; Ayer DE; Eisenman RN
    Cell Growth Differ; 1995 Jun; 6(6):623-9. PubMed ID: 7669717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased p21(ras) activity in human fibroblasts transduced with survivin enhances cell proliferation.
    Temme A; Diestelkoetter-Bachert P; Schmitz M; Morgenroth A; Weigle B; Rieger MA; Kiessling A; Rieber EP
    Biochem Biophys Res Commun; 2005 Feb; 327(3):765-73. PubMed ID: 15649412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. v-Ras and v-Raf block differentiation of transformable C3H10T1/2-derived preadipocytes at lower levels than required for neoplastic transformation.
    Raptis L; Brownell HL; Lu Y; Preston T; Narsimhan RP; Anderson S; Schaefer E; Haliotis T
    Exp Cell Res; 1997 Aug; 235(1):188-97. PubMed ID: 9281368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
    Marshall M
    Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation.
    Rey I; Taylor-Harris P; van Erp H; Hall A
    Oncogene; 1994 Mar; 9(3):685-92. PubMed ID: 8108110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
    Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
    Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling.
    Hu P; Margolis B; Schlessinger J
    Bioessays; 1993 Mar; 15(3):179-83. PubMed ID: 8489524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.